Home > > Global Unit Dose Manufacturing Market Report
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.1. OVERVIEW 3.2. IN-HOUSE 3.2.1. IN-HOUSE MARKET, BY REGION 3.2.1.1. NORTH AMERICA IN-HOUSE MARKET, BY COUNTRY 3.2.1.2. EUROPE IN-HOUSE MARKET, BY COUNTRY 3.2.1.3. ASIA IN-HOUSE MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA IN-HOUSE MARKET, BY COUNTRY 3.3. OUTSOURCING 3.3.1. OUTSOURCING MARKET, BY REGION 3.3.1.1. NORTH AMERICA OUTSOURCING MARKET, BY COUNTRY 3.3.1.2. EUROPE OUTSOURCING MARKET, BY COUNTRY 3.3.1.3. ASIA OUTSOURCING MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA OUTSOURCING MARKET, BY COUNTRY CHAPTER 4: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 4.1. OVERVIEW 4.2. LIQUID UNIT DOSE 4.2.1. LIQUID UNIT DOSE MARKET, BY REGION 4.2.1.1. NORTH AMERICA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.2. EUROPE LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.3. ASIA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.3. SOLID UNIT DOSE 4.3.1. SOLID UNIT DOSE MARKET, BY REGION 4.3.1.1. NORTH AMERICA SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.2. EUROPE SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.3. ASIA SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET, BY COUNTRY 4.4. OTHER PRODUCTS 4.4.1. OTHER PRODUCTS MARKET, BY REGION 4.4.1.1. NORTH AMERICA OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.2. EUROPE OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.3. ASIA OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET, BY COUNTRY CHAPTER 5: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY END-USE 5.1. OVERVIEW 5.2. INDEPENDENT PHARMACIES 5.2.1. INDEPENDENT PHARMACIES MARKET, BY REGION 5.2.1.1. NORTH AMERICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.2. EUROPE INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.3. ASIA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.3. LONG TERM CARE FACILITY 5.3.1. LONG TERM CARE FACILITY MARKET, BY REGION 5.3.1.1. NORTH AMERICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.2. EUROPE LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.3. ASIA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.4. HOSPITALS 5.4.1. HOSPITALS MARKET, BY REGION 5.4.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.4.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.4.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.5. OTHER END- USES 5.5.1. OTHER END- USES MARKET, BY REGION 5.5.1.1. NORTH AMERICA OTHER END- USES MARKET, BY COUNTRY 5.5.1.2. EUROPE OTHER END- USES MARKET, BY COUNTRY 5.5.1.3. ASIA OTHER END- USES MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA OTHER END- USES MARKET, BY COUNTRY CHAPTER 6: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.2. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.3. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.2.4. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.2.4.1. U.S. 6.2.4.1.1. U.S. UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.4.1.2. U.S. UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.4.1.3. U.S. UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.2.4.2. CANADA 6.2.4.2.1. CANADA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.4.2.2. CANADA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.4.2.3. CANADA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3. EUROPE 6.3.1. EUROPE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.2. EUROPE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.3. EUROPE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4. EUROPE UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.1.2. GERMANY UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.1.3. GERMANY UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.2. U.K. 6.3.4.2.1. U.K. UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.2.2. U.K. UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.2.3. U.K. UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.3. FRANCE 6.3.4.3.1. FRANCE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.3.2. FRANCE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.3.3. FRANCE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.4. ITALY 6.3.4.4.1. ITALY UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.4.2. ITALY UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.4.3. ITALY UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.5. SPAIN 6.3.4.5.1. SPAIN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.5.2. SPAIN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.5.3. SPAIN UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.6. REST OF EUROPE 6.3.4.6.1. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.6.2. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.6.3. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4. ASIA 6.4.1. ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.2. ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.3. ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4. ASIA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.4.4.1. CHINA 6.4.4.1.1. CHINA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.1.2. CHINA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.1.3. CHINA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.2. JAPAN 6.4.4.2.1. JAPAN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.2.2. JAPAN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.2.3. JAPAN UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.3. SOUTH KOREA 6.4.4.3.1. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.3.2. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.3.3. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.4. INDIA 6.4.4.4.1. INDIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.4.2. INDIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.4.3. INDIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.5. SINGAPORE 6.4.4.5.1. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.5.2. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.5.3. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.6. REST OF ASIA 6.4.4.6.1. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.6.2. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.6.3. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.2. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.3. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.5.4.1. BRAZIL 6.5.4.1.1. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.1.2. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.1.3. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.2. MEXICO 6.5.4.2.1. MEXICO UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.2.2. MEXICO UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.2.3. MEXICO UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.3. SOUTH AFRICA 6.5.4.3.1. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.3.2. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.3.3. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.4. AUSTRALIA 6.5.4.4.1. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.4.2. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.4.3. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.5. REST OF MENA 6.5.4.5.1. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.5.2. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.5.3. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY END-USE TABLE 126. REST OF MENA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION)LIST OF TABLES TABLE 01. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 02. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 03. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 04. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 06. IN-HOUSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. OUTSOURCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 17. LIQUID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. SOLID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. OTHER PRODUCTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 33. INDEPENDENT PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 34. NORTH AMERICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. EUROPE INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. ASIA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. LONG TERM CARE FACILITY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. OTHER END- USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 54. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 55. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 56. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 57. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 59. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 60. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 61. CANADA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 62. CANADA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 63. CANADA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 64. EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 65. EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 66. EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 67. EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. GERMANY UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 69. GERMANY UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 70. GERMANY UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 71. U.K. UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 72. U.K. UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 73. U.K. UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 74. FRANCE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 75. FRANCE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 76. FRANCE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 77. ITALY UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 78. ITALY UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 79. ITALY UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 80. SPAIN UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 81. SPAIN UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 82. SPAIN UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 83. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 84. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 85. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 86. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 87. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 88. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 89. ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 90. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 91. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 92. CHINA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 93. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 94. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 95. JAPAN UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 96. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 97. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 98. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 99. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 100. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 101. INDIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 102. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 103. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 104. SINGAPORE UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 105. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 106. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 107. REST OF ASIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 108. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 109. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 110. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 111. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 112. BRAZIL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 113. BRAZIL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 114. BRAZIL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 115. MEXICO UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 116. MEXICO UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 117. MEXICO UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 118. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 119. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 120. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 121. AUSTRALIA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 122. AUSTRALIA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 123. AUSTRALIA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 124. REST OF MENA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 125. REST OF MENA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 126. REST OF MENA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 3.1. OVERVIEW 3.2. IN-HOUSE 3.2.1. IN-HOUSE MARKET, BY REGION 3.2.1.1. NORTH AMERICA IN-HOUSE MARKET, BY COUNTRY 3.2.1.2. EUROPE IN-HOUSE MARKET, BY COUNTRY 3.2.1.3. ASIA IN-HOUSE MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA IN-HOUSE MARKET, BY COUNTRY 3.3. OUTSOURCING 3.3.1. OUTSOURCING MARKET, BY REGION 3.3.1.1. NORTH AMERICA OUTSOURCING MARKET, BY COUNTRY 3.3.1.2. EUROPE OUTSOURCING MARKET, BY COUNTRY 3.3.1.3. ASIA OUTSOURCING MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA OUTSOURCING MARKET, BY COUNTRY CHAPTER 4: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 4.1. OVERVIEW 4.2. LIQUID UNIT DOSE 4.2.1. LIQUID UNIT DOSE MARKET, BY REGION 4.2.1.1. NORTH AMERICA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.2. EUROPE LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.3. ASIA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET, BY COUNTRY 4.3. SOLID UNIT DOSE 4.3.1. SOLID UNIT DOSE MARKET, BY REGION 4.3.1.1. NORTH AMERICA SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.2. EUROPE SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.3. ASIA SOLID UNIT DOSE MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET, BY COUNTRY 4.4. OTHER PRODUCTS 4.4.1. OTHER PRODUCTS MARKET, BY REGION 4.4.1.1. NORTH AMERICA OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.2. EUROPE OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.3. ASIA OTHER PRODUCTS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET, BY COUNTRY CHAPTER 5: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY END-USE 5.1. OVERVIEW 5.2. INDEPENDENT PHARMACIES 5.2.1. INDEPENDENT PHARMACIES MARKET, BY REGION 5.2.1.1. NORTH AMERICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.2. EUROPE INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.3. ASIA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET, BY COUNTRY 5.3. LONG TERM CARE FACILITY 5.3.1. LONG TERM CARE FACILITY MARKET, BY REGION 5.3.1.1. NORTH AMERICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.2. EUROPE LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.3. ASIA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET, BY COUNTRY 5.4. HOSPITALS 5.4.1. HOSPITALS MARKET, BY REGION 5.4.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 5.4.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 5.4.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 5.5. OTHER END- USES 5.5.1. OTHER END- USES MARKET, BY REGION 5.5.1.1. NORTH AMERICA OTHER END- USES MARKET, BY COUNTRY 5.5.1.2. EUROPE OTHER END- USES MARKET, BY COUNTRY 5.5.1.3. ASIA OTHER END- USES MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA OTHER END- USES MARKET, BY COUNTRY CHAPTER 6: GLOBAL UNIT DOSE MANUFACTURING MARKET, BY REGION 6.1. OVERVIEW 6.2. NORTH AMERICA 6.2.1. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.2. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.3. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.2.4. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.2.4.1. U.S. 6.2.4.1.1. U.S. UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.4.1.2. U.S. UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.4.1.3. U.S. UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.2.4.2. CANADA 6.2.4.2.1. CANADA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.2.4.2.2. CANADA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.2.4.2.3. CANADA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3. EUROPE 6.3.1. EUROPE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.2. EUROPE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.3. EUROPE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4. EUROPE UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.3.4.1. GERMANY 6.3.4.1.1. GERMANY UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.1.2. GERMANY UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.1.3. GERMANY UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.2. U.K. 6.3.4.2.1. U.K. UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.2.2. U.K. UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.2.3. U.K. UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.3. FRANCE 6.3.4.3.1. FRANCE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.3.2. FRANCE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.3.3. FRANCE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.4. ITALY 6.3.4.4.1. ITALY UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.4.2. ITALY UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.4.3. ITALY UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.5. SPAIN 6.3.4.5.1. SPAIN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.5.2. SPAIN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.5.3. SPAIN UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.3.4.6. REST OF EUROPE 6.3.4.6.1. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.3.4.6.2. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.3.4.6.3. REST OF EUROPE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4. ASIA 6.4.1. ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.2. ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.3. ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4. ASIA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.4.4.1. CHINA 6.4.4.1.1. CHINA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.1.2. CHINA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.1.3. CHINA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.2. JAPAN 6.4.4.2.1. JAPAN UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.2.2. JAPAN UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.2.3. JAPAN UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.3. SOUTH KOREA 6.4.4.3.1. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.3.2. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.3.3. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.4. INDIA 6.4.4.4.1. INDIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.4.2. INDIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.4.3. INDIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.5. SINGAPORE 6.4.4.5.1. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.5.2. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.5.3. SINGAPORE UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.4.4.6. REST OF ASIA 6.4.4.6.1. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.4.4.6.2. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.4.4.6.3. REST OF ASIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5. MIDDLE EAST & AFRICA 6.5.1. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.2. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.3. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4. MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET, BY COUNTRY 6.5.4.1. BRAZIL 6.5.4.1.1. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.1.2. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.1.3. BRAZIL UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.2. MEXICO 6.5.4.2.1. MEXICO UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.2.2. MEXICO UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.2.3. MEXICO UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.3. SOUTH AFRICA 6.5.4.3.1. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.3.2. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.3.3. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.4. AUSTRALIA 6.5.4.4.1. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.4.2. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.4.3. AUSTRALIA UNIT DOSE MANUFACTURING MARKET, BY END-USE 6.5.4.5. REST OF MENA 6.5.4.5.1. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY SOURCING 6.5.4.5.2. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY PRODUCT 6.5.4.5.3. REST OF MENA UNIT DOSE MANUFACTURING MARKET, BY END-USE TABLE 01. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 02. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 03. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 04. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 06. IN-HOUSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 07. NORTH AMERICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. EUROPE IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. ASIA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. MIDDLE EAST & AFRICA IN-HOUSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 11. OUTSOURCING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 12. NORTH AMERICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. EUROPE OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. ASIA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. MIDDLE EAST & AFRICA OUTSOURCING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 17. LIQUID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA LIQUID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. SOLID UNIT DOSE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA SOLID UNIT DOSE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. OTHER PRODUCTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA OTHER PRODUCTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 33. INDEPENDENT PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 34. NORTH AMERICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. EUROPE INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. ASIA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. MIDDLE EAST & AFRICA INDEPENDENT PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. LONG TERM CARE FACILITY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 39. NORTH AMERICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. EUROPE LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. ASIA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. MIDDLE EAST & AFRICA LONG TERM CARE FACILITY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. OTHER END- USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA OTHER END- USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. GLOBAL UNIT DOSE MANUFACTURING MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 54. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($MILLION) TABLE 55. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 56. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 57. NORTH AMERICA UNIT DOSE MANUFACTURING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 59. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 60. U.S. UNIT DOSE MANUFACTURING MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 61. CANADA UNIT DOSE MANUFACTURING MARKET VALUE, BY SOURCING, 2023-2030, ($ MILLION) TABLE 62. CANADA UNIT DOSE MANUFACTURING MARKET